Severity of Illness Index

"Severity of Illness Index" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder.

Descriptor ID	D012720
MeSH Number(s)	E05.318.308.980.438.475.456.500 N05.715.360.300.800.438.375.364.500 N06.850.520.308.980.438.475.364.500
Concept/Terms	Severity of Illness Index Severity of Illness Index Illness Index Severities Illness Index Severity Index Severities, Illness Index Severity, Illness

Below are MeSH descriptors whose meaning is more general than "Severity of Illness Index".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Epidemiologic Methods [E05.318]
Data Collection [E05.318.308]
Surveys and Questionnaires [E05.318.308.980]
Health Surveys [E05.318.308.980.438]
Health Status Indicators [E05.318.308.980.438.475]
Patient Acuity [E05.318.308.980.438.475.456]
Severity of Illness Index [E05.318.308.980.438.475.456.500]
Health Care [N]
Health Care Quality, Access, and Evaluation [N05]
Quality of Health Care [N05.715]
Health Care Evaluation Mechanisms [N05.715.360]
Data Collection [N05.715.360.300]
Surveys and Questionnaires [N05.715.360.300.800]
Health Surveys [N05.715.360.300.800.438]
Health Status Indicators [N05.715.360.300.800.438.375]
Patient Acuity [N05.715.360.300.800.438.375.364]
Severity of Illness Index [N05.715.360.300.800.438.375.364.500]
Environment and Public Health [N06]
Public Health [N06.850]
Epidemiologic Methods [N06.850.520]
Data Collection [N06.850.520.308]
Surveys and Questionnaires [N06.850.520.308.980]
Health Surveys [N06.850.520.308.980.438]
Health Status Indicators [N06.850.520.308.980.438.475]
Patient Acuity [N06.850.520.308.980.438.475.364]
Severity of Illness Index [N06.850.520.308.980.438.475.364.500]

Below are MeSH descriptors whose meaning is related to "Severity of Illness Index".

Below are MeSH descriptors whose meaning is more specific than "Severity of Illness Index".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Severity of Illness Index" by people in this website by year, and whether "Severity of Illness Index" was a major or minor topic of these publications.

Bar chart showing 2700 publications over 30 distinct years, with a maximum of 181 publications in 2014

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1991	1	3	4
1992	1	1	2
1993	1	8	9
1994	2	16	18
1995	0	7	7
1996	0	11	11
1997	0	12	12
1998	2	15	17
1999	2	35	37
2000	1	35	36
2001	0	33	33
2002	2	65	67
2003	3	86	89
2004	5	90	95
2005	9	112	121
2006	9	112	121
2007	13	130	143
2008	12	129	141
2009	10	145	155
2010	13	124	137
2011	12	148	160
2012	20	124	144
2013	21	136	157
2014	16	165	181
2015	21	154	175
2016	18	130	148
2017	11	131	142
2018	17	131	148
2019	18	117	135
2020	6	49	55

Below are the most recent publications written about "Severity of Illness Index" by people in Profiles.

Yee M, David Cohen E, Haak J, Dylag AM, O'Reilly MA. Neonatal hyperoxia enhances age-dependent expression of SARS-CoV-2 receptors in mice. Sci Rep. 2020 12 28; 10(1):22401.

View in: PubMed
Yonas E, Alwi I, Pranata R, Huang I, Lim MA, Yamin M, Nasution SA, Setiati S, Virani SS. Elevated interleukin levels are associated with higher severity and mortality in COVID 19 - A systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr. 2020 Nov-Dec; 14(6):2219-2230.

View in: PubMed
Santoro SL, Chicoine B, Jasien JM, Kim JL, Stephens M, Bulova P, Capone G. Pneumonia and respiratory infections in Down syndrome: A scoping review of the literature. Am J Med Genet A. 2021 01; 185(1):286-299.

View in: PubMed
Abdel-Wahab R, Hassan MM, George B, Carmagnani Pestana R, Xiao L, Lacin S, Yalcin S, Shalaby AS, Al-Shamsi HO, Raghav K, Wolff RA, Yao JC, Girard L, Haque A, Duda DG, Dima S, Popescu I, Elghazaly HA, Vauthey JN, Aloia TA, Tzeng CW, Chun YS, Rashid A, Morris JS, Amin HM, Kaseb AO. Impact of Integrating Insulin-Like Growth Factor 1 Levels into Model for End-Stage Liver Disease Score for Survival Prediction in Hepatocellular Carcinoma Patients. Oncology. 2020; 98(12):836-846.

View in: PubMed
Huang J, Emori H, Ding D, Kubo T, Yu W, Huang P, Zhang S, Gutiérrez-Chico JL, Akasaka T, Wijns W, Tu S. Diagnostic performance of intracoronary optical coherence tomography-based versus angiography-based fractional flow reserve for the evaluation of coronary lesions. EuroIntervention. 2020 Sep 18; 16(7):568-576.

View in: PubMed
Citron F, Perelli L, Deem AK, Genovese G, Viale A. Leukotrienes, a potential target for Covid-19. Prostaglandins Leukot Essent Fatty Acids. 2020 10; 161:102174.

View in: PubMed
Yalniz C, Morani AC, Waguespack SG, Elsayes KM. Imaging of Adrenal-Related Endocrine Disorders. Radiol Clin North Am. 2020 Nov; 58(6):1099-1113.

View in: PubMed
Cohen JB, Hanff TC, Corrales-Medina V, William P, Renna N, Rosado-Santander NR, Rodriguez-Mori JE, Spaak J, Andrade-Villanueva J, Chang TI, Barbagelata A, Alfonso CE, Bernales-Salas E, Coacalla J, Castro-Callirgos CA, Tupayachi-Venero KE, Medina C, Valdivia R, Villavicencio M, Vasquez CR, Harhay MO, Chittams J, Sharkoski T, Byrd JB, Edmonston DL, Sweitzer N, Chirinos JA. Randomized elimination and prolongation of ACE inhibitors and ARBs in coronavirus 2019 (REPLACE COVID) Trial Protocol. J Clin Hypertens (Greenwich). 2020 10; 22(10):1780-1788.

View in: PubMed
Shannon VR, Anderson R, Blidner A, Choi J, Cooksley T, Dougan M, Glezerman I, Ginex P, Girotra M, Gupta D, Johnson DB, Suarez-Almazor ME, Rapoport BL. Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-related adverse events: pulmonary toxicity. Support Care Cancer. 2020 Dec; 28(12):6145-6157.

View in: PubMed
Parodis I, Gokaraju S, Zickert A, Vanarsa K, Zhang T, Habazi D, Botto J, Serdoura Alves C, Giannopoulos P, Larsson A, Svenungsson E, Gunnarsson I, Mohan C. ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus. Rheumatology (Oxford). 2020 09 01; 59(9):2237-2249.

View in: PubMed

People

Explore

Similar Concepts

Top Journals